Hims & Hers Health (HIMS) announced eligible customers can access 6 months of prescription-only Wegovy at a new, affordable price, “making proven obesity care and treatments more accessible, more affordable, and more connected for millions of Americans,” the company stated. Starting today, new customers eligible for Wegovy on the Hims & Hers platform can access their care for $549 per month for 6 months for a limited-time only, the company stated. “We are always looking for long-term, sustainable ways to increase access to care for our customers. This is another example of how we’re working together with the industry to bring people closer to the care and treatments they need,” said Andrew Dudum, CEO and co-founder of Hims & Hers.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HIMS:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue